Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ENVX stock price vs ABBV: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ABBV's multiple
Needs ABBV P/S.
Implied fair value · at ENVX's multiple
Needs ENVX P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ENVX FY 2025 (ended Dec 28, 2025) · ABBV FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Enovix Corporation · implied price per share
Bear
-$0.37
Base
-$0.43
Bull
-$0.50
AbbVie Inc. · implied price per share
Bear
$53.48
Base
$62.92
Bull
$72.36
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.95x
-19.88x
Net debt / EBITDA
Leverage against operating earnings
-0.15x
2.90x
Cash and equivalents
Liquid reserves on the balance sheet
$512.04M
$5.26B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
QuantumScape Corp
ENVX vs QS
Eos Energy Enterprises, Inc.
ENVX vs EOSE
Microvast Holdings, Inc.
ENVX vs MVST
AEHR TEST SYSTEMS
ENVX vs AEHR
Pfizer Inc.
ENVX vs PFE
Johnson & Johnson
ENVX vs JNJ
Merck & Co., Inc.
ENVX vs MRK
Eli Lilly and Company
ENVX vs LLY
Amgen Inc.
ENVX vs AMGN
Gilead Sciences, Inc.
ENVX vs GILD
$529.37M
$65.00B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
